Uruguay once again breaks record of daily positives and active COVID-19

Uruguay This Tuesday registered a new record of daily COVID-19 infections, with 7,182 positives, and of active cases, with 49,373, according to the daily report of the National Emergency System (Sinae).

Of the 24,019 analyzes carried out, 7,182 were positive, so the country accumulates 463,357 total cases since the health emergency was declared on March 13, 2020 due to the detection of the first four infections by the SARS-CoV-2 coronavirus.

Of this total, 49,373 are people who are suffering from the disease and 46 of them are in intensive care centers (ICU).

On this day there were three fatalities, so the total number of deaths from COVID-19 increased to 6,202.

On December 29, Uruguay confirmed the arrival of the omicron variant of COVID-19 after the increase in cases in recent weeks led scientists in the country to suspect that it had already entered and genomic sequencing led to its detection.

The Minister of Public Health, Daniel Salinas, explained at that time that the health authorities expected a “similar behavior” to that in the world, that is, a “very strong” increase in cases despite vaccination, although with particular characteristics. .

This Monday, the president of the country, Luis Lacalle Pou, gave a press conference with Salinas in which he emphasized that they do not plan to close the borders again – which reopened on November 1 after 20 months – and that the country, despite to the high numbers of positives, it has “the great defense” of its high level of vaccinated with two or three doses.

In addition, this country eliminated the obligation for tourists to undergo a PCR test to detect the SARS-CoV-2 coronavirus one week after entering.

Regarding vaccination, according to the web monitor developed by the Ministry of Public Health (MSP) until 18.25 hours (21.25 GMT) this Tuesday, 2,680,442 people (75.65% of the population) completed their schedule of vaccination of the Chinese pharmaceutical companies Sinovac, the Anglo-Swedish AstraZeneca and the American Pfizer.

Furthermore, 96,849 people were inoculated with only the first dose, while 1,585,218 received a third dose.